Frontiers in Medicine (Dec 2021)

NTF3 Correlates With Prognosis and Immune Infiltration in Hepatocellular Carcinoma

  • Rongqiang Liu,
  • Rongqiang Liu,
  • Rongqi Li,
  • Haoyuan Yu,
  • Jianrong Liu,
  • Shiyang Zheng,
  • Yang Li,
  • Linsen Ye

DOI
https://doi.org/10.3389/fmed.2021.795849
Journal volume & issue
Vol. 8

Abstract

Read online

Background: The potential role of Neurotrophic factor-3(NTF3) in liver cancer is unknown. Therefore, we aimed to explore the clinical value of NTF3 in hepatocellular carcinoma (HCC).Methods: We used a variety of databases to analyze the expression, relationship with prognosis and immune significance of NTF3 in liver cancer through bioinformatics.Results: NTF3 was low expressed in HCC and was an independent prognostic factor in patients with HCC. CIBERSORT analysis indicated that NTF3 expression was positively correlated with CD4+ cells, mast cells, NK cells, macrophages and B cells in the tumor microenvironment. Furthermore, we found that NTF3 expression was negatively correlated with the immune checkpoints PD-L1, TIGIT and TIM-3. Functional network analysis revealed that NTF3 regulates HCC progression through a variety of cancer-related kinases, transcription factors and signaling pathways.Conclusions: We demonstrate that NTF3 correlates with prognosis and immune infiltration in HCC.

Keywords